Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 7347065, 6 pages
http://dx.doi.org/10.1155/2016/7347065
Research Article

Implication of Cytotoxic Helicobacter pylori Infection in Autoimmune Diabetes

1Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy
2Department of Clinical and Experimental Medicine, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy
3Baylor College of Medicine, Houston, TX, USA

Received 11 September 2015; Accepted 23 November 2015

Academic Editor: Carlos Martinez Salgado

Copyright © 2016 Alessandro P. Delitala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Cave, “How is helicobacter pylori transmitted?” Gastroenterology, vol. 113, no. 6, pp. S9–S14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Megraud, “Epidemiology of Helicobacter pylori infection,” Gastroenterology Clinics of North America, vol. 22, no. 1, pp. 73–88, 1993. View at Google Scholar · View at Scopus
  3. G. Realdi, M. P. Dore, and L. Fastame, “Extradigestive manifestations of Helicobacter pylori infection: fact and fiction,” Digestive Diseases and Sciences, vol. 44, no. 2, pp. 229–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Franceschi, A. Tortora, G. Gasbarrini, and A. Gasbarrini, “Helicobacter pylori and extragastric diseases,” Helicobacter, vol. 19, no. 1, pp. 52–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Crabtree, “Immune and inflammatory responses to Helicobacter pylori infection,” Scandinavian Journal of Gastroenterology—Supplement, vol. 215, pp. 3–10, 1996. View at Google Scholar · View at Scopus
  6. X. Zhou, C. Zhang, J. Wu, and G. Zhang, “Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 200–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Polyzos, J. Kountouras, C. Zavos, and G. Deretzi, “The association between Helicobacter pylori infection and insulin resistance: a systematic review,” Helicobacter, vol. 16, no. 2, pp. 79–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Aydemir, T. Bayraktaroglu, M. Sert et al., “The effect of Helicobacter pylori on insulin resistance,” Digestive Diseases and Sciences, vol. 50, no. 11, pp. 2090–2093, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Y. Jeon, M. N. Haan, C. Cheng et al., “Helicobacter pylori infection is associated with an increased rate of diabetes,” Diabetes Care, vol. 35, no. 3, pp. 520–525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. S. Smyk, A. L. Koutsoumpas, M. G. Mytilinaiou, E. I. Rigopoulou, L. I. Sakkas, and D. P. Bogdanos, “Helicobacter pylori and autoimmune disease: cause or bystander,” World Journal of Gastroenterology, vol. 20, no. 3, pp. 613–629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Pocecco, E. Buratti, A. Tommasini, G. Torre, and T. Not, “High risk of Helicobacter pylori infection associated with cow's milk antibodies in young diabetics,” Acta Paediatrica, vol. 86, no. 7, pp. 700–703, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. M. P. Dore, M. Bilotta, H. M. Malaty et al., “Diabetes mellitus and Helicobacter pylori infection,” Nutrition, vol. 16, no. 6, pp. 407–410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Kojecký, J. Roubalík, and N. Bartoníková, “Helicobacter pylori in patients with diabetes mellitus,” Vnitrni Lekarstvi, vol. 39, no. 6, pp. 581–584, 1993. View at Google Scholar · View at Scopus
  14. J.-T. Lin, J. T. Wang, T. H. Wang, M. S. Wu, T. K. Lee, and C. J. Chen, “Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan,” Scandinavian Journal of Gastroenterology, vol. 28, no. 12, pp. 1067–1072, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Candelli, D. Rigante, A. Schiavino et al., “High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 11, pp. 1468–1472, 2012. View at Google Scholar · View at Scopus
  16. P. Z. Zimmet, “The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography,” Diabetes Care, vol. 18, no. 7, pp. 1050–1064, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Oluyemi, E. Anomneze, S. Smith, and O. Fasanmade, “Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria,” BMC Research Notes, vol. 5, article 284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Maioli, G. M. Pes, G. Delitala et al., “Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults,” European Journal of Endocrinology, vol. 163, no. 4, pp. 541–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. M. Pes, A. P. Delitala, A. Errigo, G. Delitala, and M. P. Dore, “Clustering of immunological, metabolic and genetic features in latent autoimmune diabetes in adults: evidence from principal component analysis,” Internal and Emergency Medicine, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  20. N. Figura, A. Palazzuoli, D. Vaira et al., “Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide,” Journal of Clinical Pathology, vol. 67, no. 3, pp. 251–257, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Delitala, G. Fanciulli, M. Zoledziewska et al., “Allelic variant in CTLA4 is associated with thyroid failure and faster β-cell exhaustion in latent autoimmune diabetes in adults,” Journal of Diabetes, vol. 7, no. 1, pp. 68–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. P. Dore, G. Marras, C. Rocchi et al., “Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients,” Internal and Emergency Medicine, vol. 10, no. 7, pp. 787–794, 2015. View at Publisher · View at Google Scholar
  23. B. R. Devrajani, S. Z. A. Shah, A. A. Soomro, and T. Devrajani, “Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study,” International Journal of Diabetes in Developing Countries, vol. 30, no. 1, pp. 22–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bener, R. Micallef, M. Afifi, M. Derbala, H. M. Al-Mulla, and M. A. Usmani, “Association between type 2 diabetes mellitus and Helicobacter pylori infection,” Turkish Journal of Gastroenterology, vol. 18, no. 4, pp. 225–229, 2007. View at Google Scholar · View at Scopus
  25. N. E. Gulcelik, E. Kaya, B. Demirbas et al., “Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy,” Journal of Endocrinological Investigation, vol. 28, no. 3, pp. 214–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Bajaj, L. Rekwal, S. P. Misra, V. Misra, R. K. Yadav, and A. Srivastava, “Association of helicobacter pylori infection with type 2 diabetes,” Indian Journal of Endocrinology and Metabolism, vol. 18, pp. 694–699, 2014. View at Google Scholar
  27. R. Anastasios, C. Goritsas, C. Papamihail, R. Trigidou, P. Garzonis, and A. Ferti, “Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings,” European Journal of Internal Medicine, vol. 13, no. 6, pp. 376–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. G. T. C. Ko, F. K. L. Chan, W.-B. Chan et al., “Helicobacter pylori infection in chinese subjects with type 2 diabetes,” Endocrine Research, vol. 27, no. 1-2, pp. 171–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. O. G. Stanciu, A. Trifan, C. Sfarti, C. Cojocariu, and C. Stanciu, “Helicobacter pylori infection in patients with diabetes mellitus,” Revista Mcedico-Hirurgicala a Societatii de Medici si Naturalisti din Iasi's, vol. 107, no. 1, pp. 59–65, 2003. View at Google Scholar · View at Scopus
  30. S. A. Hamed, N. F. Amine, G. M. Galal et al., “Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 2, pp. 86–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Buzzetti, S. Di Pietro, A. Giaccari et al., “High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes,” Diabetes Care, vol. 30, no. 4, pp. 932–938, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Monti, M. Scirpoli, A. Rigamonti et al., “Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes,” The Journal of Immunology, vol. 179, no. 9, pp. 5785–5792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Songini, M. Loche, S. Muntoni et al., “Increasing prevalence of juvenile onset type 1 (insulin-dependent) diabetes mellitus in Sardinia: the military service approach,” Diabetologia, vol. 36, no. 6, pp. 547–552, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Yamaoka, T. Kudo, H. Lu, A. Casola, A. R. Brasier, and D. Y. Graham, “Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection,” Gastroenterology, vol. 126, no. 4, pp. 1030–1043, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Borody, Z. Ren, G. Pang, and R. Clancy, “Impaired host immunity contributes to Helicobacter pylori eradication failure,” The American Journal of Gastroenterology, vol. 97, no. 12, pp. 3032–3037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. D. A. de Luis, H. de la Calle, G. Roy et al., “Helicobacter pylori infection and insulin-dependent diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 39, no. 2, pp. 143–146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. P. L. Jeffery, M. A. McGuckin, and S. K. Linden, “Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase,” World Journal of Gastroenterology, vol. 17, no. 10, pp. 1249–1260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Roper, F. Francois, P. L. Shue et al., “Leptin and ghrelin in relation to Helicobacter pylori status in adult males,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 6, pp. 2350–2357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Kaneko, T. Konagaya, and K. Kusugami, “Helicobacter pylori and gut hormones,” Journal of Gastroenterology, vol. 37, no. 2, pp. 77–86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. J. S. Muhammad, T. Sugiyama, and S. F. Zaidi, “Gastric pathophysiological Ins and outs of helicobacter pylori: a review,” Journal of the Pakistan Medical Association, vol. 63, no. 12, pp. 1528–1533, 2013. View at Google Scholar · View at Scopus
  41. L. Frulloni, C. Lunardi, R. Simone et al., “Identification of a novel antibody associated with autoimmune pancreatitis,” The New England Journal of Medicine, vol. 361, no. 22, pp. 2135–2142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Y. Graham, “Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits,” Gastroenterology, vol. 148, no. 4, pp. 719.e3–731.e3, 2015. View at Publisher · View at Google Scholar
  43. M. P. Dore, A. R. Sepulveda, P. P. Bacciu et al., “Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques,” Digestive Diseases and Sciences, vol. 48, no. 5, pp. 945–951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Franceschi, A. R. Sepulveda, A. Gasbarrini et al., “Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis,” Circulation, vol. 106, no. 4, pp. 430–434, 2002. View at Publisher · View at Google Scholar · View at Scopus